节点文献

我国药品费用不合理增长的“四大”源头及对策思考

Measures for Control of Drug Expenditure Rise

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 吴龙

【Author】 Wu LongHealth Insurance Bureau of Shanghai, Shanghai, 200002, PRC

【机构】 上海市医疗保险局 上海 200002

【摘要】 针对我国药品费用不合理增长的迅猛势头,剖析了引起药品费用不合理增长的四大源头:政策源头是国家缺乏对药品工业宏观控制;补偿源头是医院组织行为的扭曲;直接源头是医师商业性处方行为和落后的传统处方行为;根本源头是患者对药品资源的无限需求和无费用意识。并探讨了控制四大源头的相应对策。

【Abstract】 Measures for control of irrational rising of drug expenditure are discussed from aspects: increase macro - level research, prediction, guidance of drug production and market in terms of priorities, choices, supply - demand relations, price management policy; facilitate in - service training and management development to improve the quality of prescription practice; make actual drug diversity a clinical advantage for physicians to choose different mechanisms of action and different prcfiles of interactions for their individual patients; allowing flexibility on the part of physician to adjust drug prescription to what is most favorable for the patient; manage need and expense in ways that move them in the direction of compatibility; improve management policy which can integrate services and promote cost - effectiveness.

  • 【文献出处】 中国医院管理 ,Chinese Hospital Management , 编辑部邮箱 ,2000年04期
  • 【分类号】R95
  • 【被引频次】18
  • 【下载频次】126
节点文献中: 

本文链接的文献网络图示:

本文的引文网络